Fortunately for most GLP-1 users, the gastrointestinal side effects are mild to moderate in severity, generally tolerable and tend to improve with time, especially with careful and slow dose titration
Finally, research also showed that taking some drugs in addition to antibiotics may lower TMAO levels [111]
Without resistance training and protein optimization, expect approximately 31-38% of total weight lost to come from lean mass
A recent study in Denmark showed that GLP-1 agonists may improve the disease course of IBD
You are likely focused on nutrition, rest, and minimizing environmental toxins
Clinical trials compare people taking the drug with those on a placebo and demonstrate that those who continue using retatrutide recoup less weight